Talking Numbers – CNBC | Should you bag Coach shares?

Coach shares fell like a bag of bricks Tuesday to a its lowest level in nearly five years after the luxury goods company reported mixed earnings results. Click here if you can’t see the video below.

Click here to post a comment on Talking Numbers – CNBC | Should you bag Coach shares?


Talking Numbers – CNBC | Have Ebola fears made this sector a major buy?

After getting slammed on Ebola fears, this sector has rallied 8 percent in the past week.

Click here to post a comment on Talking Numbers – CNBC | Have Ebola fears made this sector a major buy?


Talking Numbers – CNBC | Three Reasons to Avoid this Struggling Retailer

This teen retailer has been trying to make a comeback, but the charts are setting up for a steeper decline.

Click here to post a comment on Talking Numbers – CNBC | Three Reasons to Avoid this Struggling Retailer


Talking Numbers – CNBC | AstraZeneca Hazardous to Your Financial Health?

AstraZeneca (NYSE: AZN) may have just received a double dose of good news, but is its stock a threat to your portfolio? Watch the video to find out how Chief Income Strategist Marc Lichtenfeld diagnosed this stock.

Click here to post a comment on Talking Numbers – CNBC | AstraZeneca Hazardous to Your Financial Health?


Talking Numbers – CNBC | Apple Setting Up for a Huge Move Higher?

Apple shares are approaching their split-adjusted all-time high. Is now the time to bite into Apple’s stock?

Click here to post a comment on Talking Numbers – CNBC | Apple Setting Up for a Huge Move Higher?


Talking Numbers – CNBC | This Chart Spells Trouble for Pfizer

Pfizer shares are down nearly 9% in the past 3 months and severely lagging the broader market. Watch the video to find out if The Oxford Club’s Marc Lichtenfeld and Carter Worth of Sterne Agee think this stock is going to recover anytime soon.

Click here to post a comment on Talking Numbers – CNBC | This Chart Spells Trouble for Pfizer


Talking Numbers – CNBC | Why it could be time to start lovin’ McDonald’s

McDonald’s global sales are rising, but fast-food rivals like Burger King Worldwide and Wendy’s are eating its lunch right here at home. Are shares in the fast-food giant a bargain right now? Watch The Oxford Club’s Marc Lichtenfeld and Ari Wald, head of technical analysis at Oppenheimer, discuss the fundamentals.

Click here to post a comment on Talking Numbers – CNBC | Why it could be time to start lovin’ McDonald’s


Talking Numbers – CNBC | Netflix – Only four down days in May

Netflix is priced for perfection – and Marc Lichtenfeld doesn’t like that. The valuation is ridiculous, currently trading at 102 times its estimated 2014 earnings and 61 times its estimated 2015 earnings. Watch the discussion for the full analysis.

Click here to post a comment on Talking Numbers – CNBC | Netflix – Only four down days in May


Talking Numbers – CNBC | This chipmaker’s stock could see a DRAM-atic move up

Micron Technology (NASDAQ:MU) is on the right side of the supply/demand equation. The demand for DRAM is very strong right now. It’s expected to grow about 20 to 30 percent this year and supply is constrained. So, Micron has a lot of pricing power and visibility into the future.

Click here to post a comment on Talking Numbers – CNBC | This chipmaker’s stock could see a DRAM-atic move up


Talking Numbers – CNBC: Dominos Fails to Deliver

Shares of Domino’s dropped more than 3 percent Thursday, despite reporting earnings on par with street expectations, and better than expected revenues. Still, the stock is up 37 percent over the past year, so should you add a slice of Domino’s to your portfolio? Marc Lichtenfeld doesn’t think so, and he has two reasons why you shouldn’t invest in Domino’s: rising commodity prices and the stock is expensive.

Click here to post a comment on Talking Numbers – CNBC: Dominos Fails to Deliver